[go: up one dir, main page]

DK2308497T3 - Farmaceutisk sammensætning omfattende glycosaminoglycaner og brug heraf ved behandling af kroniske mavesår - Google Patents

Farmaceutisk sammensætning omfattende glycosaminoglycaner og brug heraf ved behandling af kroniske mavesår

Info

Publication number
DK2308497T3
DK2308497T3 DK09772593.1T DK09772593T DK2308497T3 DK 2308497 T3 DK2308497 T3 DK 2308497T3 DK 09772593 T DK09772593 T DK 09772593T DK 2308497 T3 DK2308497 T3 DK 2308497T3
Authority
DK
Denmark
Prior art keywords
glycosaminoglycans
treatment
pharmaceutical composition
gastric ulcer
chronic gastric
Prior art date
Application number
DK09772593.1T
Other languages
English (en)
Inventor
Encina Iván López-Belmonte
Mayordomo María De Los Angeles Canales
Miranda Elena Cebadera
Original Assignee
Rovi Lab Farmaceut Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rovi Lab Farmaceut Sa filed Critical Rovi Lab Farmaceut Sa
Application granted granted Critical
Publication of DK2308497T3 publication Critical patent/DK2308497T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK09772593.1T 2008-07-01 2009-06-30 Farmaceutisk sammensætning omfattende glycosaminoglycaner og brug heraf ved behandling af kroniske mavesår DK2308497T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200802002A ES2340902B1 (es) 2008-07-01 2008-07-01 Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.
PCT/ES2009/070264 WO2010000904A1 (es) 2008-07-01 2009-06-30 Composición farmacéutica con glicosaminoglicanos y su uso en tratamiento de úlceras crónicas

Publications (1)

Publication Number Publication Date
DK2308497T3 true DK2308497T3 (da) 2014-07-14

Family

ID=41319881

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09772593.1T DK2308497T3 (da) 2008-07-01 2009-06-30 Farmaceutisk sammensætning omfattende glycosaminoglycaner og brug heraf ved behandling af kroniske mavesår

Country Status (15)

Country Link
US (2) US20110201572A1 (da)
EP (1) EP2308497B1 (da)
JP (1) JP2011526608A (da)
CN (1) CN102176915A (da)
AU (1) AU2009265623B2 (da)
BR (1) BRPI0913839A2 (da)
CA (1) CA2766483C (da)
CY (1) CY1115780T1 (da)
DK (1) DK2308497T3 (da)
ES (2) ES2340902B1 (da)
MX (1) MX2010014552A (da)
PL (1) PL2308497T3 (da)
PT (1) PT2308497E (da)
RU (1) RU2011103459A (da)
WO (3) WO2010000904A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2357601B1 (es) * 2011-01-26 2012-03-21 Laboratorios Farmacéuticos Rovi, S.A. Procedimiento de preparación de derivados de glicosaminoglicanos donadores de óxido n�?trico y su uso en tratamiento de úlceras crónicas.
JP2012245943A (ja) * 2011-05-31 2012-12-13 Hitachi Automotive Systems Ltd 制御装置
JP5942133B2 (ja) * 2012-09-11 2016-06-29 学校法人関西文理総合学園 蛍光プローブ及びこれを用いた酵素活性検出方法
EP3271405A1 (en) * 2015-03-20 2018-01-24 Aarhus Universitet Inhibitors of pcsk9 for treatment of lipoprotein metabolism disorders
EP3273239A1 (en) 2016-07-19 2018-01-24 Laboratorios Farmacéuticos Rovi, S.A. Procedure of analysis of glycosaminoglycans, heparins and their derivatives by nuclear magnetic resonance
TWI698241B (zh) * 2017-09-05 2020-07-11 國立成功大學 用於治療缺血的肝素組合物
CN114072430B (zh) * 2020-04-27 2023-07-28 罗威制药股份有限公司 低分子量肝素获取程序以及由此获得的低分子量肝素

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004A (en) * 1849-01-09 chinnqck
CH636888A5 (fr) * 1977-08-08 1983-06-30 Choay Sa Heparines purifiees et leur preparation.
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
IT1245907B (it) * 1991-05-17 1994-10-25 Alfa Wassermann Spa Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.
EP1033375A4 (en) * 1997-11-20 2002-04-24 Ikuo Yamashina MODIFICATION OF LOW MOLECULAR MASS HEPARIN AND REMEDY FOR SKIN Ulcer
ES2161615B1 (es) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
WO2002077155A2 (en) 2001-01-08 2002-10-03 Human Genome Sciences, Inc. Keratinocyte growth factor-2
CU23043A1 (es) 2001-12-20 2005-05-20 Ct Ingenieria Genetica Biotech Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico.
AU2003219421A1 (en) 2002-05-02 2003-11-17 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
US20060040896A1 (en) * 2004-08-18 2006-02-23 Paringenix, Inc. Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
CU23388B6 (es) 2006-01-31 2009-07-16 Ct Ingenieria Genetica Biotech Composición farmacéutica de microesferas para prevenir la amputación del pie diabético

Also Published As

Publication number Publication date
CY1115780T1 (el) 2017-01-25
US9211305B2 (en) 2015-12-15
WO2010000905A1 (es) 2010-01-07
JP2011526608A (ja) 2011-10-13
PT2308497E (pt) 2014-07-24
PL2308497T3 (pl) 2014-10-31
EP2308497A1 (en) 2011-04-13
CN102176915A (zh) 2011-09-07
ES2476966T3 (es) 2014-07-15
US20110201572A1 (en) 2011-08-18
ES2340902B1 (es) 2011-05-03
US20140066402A1 (en) 2014-03-06
MX2010014552A (es) 2011-04-26
CA2766483A1 (en) 2010-01-07
WO2010000904A1 (es) 2010-01-07
ES2340902A1 (es) 2010-06-10
AU2009265623B2 (en) 2014-11-20
CA2766483C (en) 2017-01-17
EP2308497B1 (en) 2014-04-16
RU2011103459A (ru) 2012-08-10
AU2009265623A1 (en) 2010-01-07
BRPI0913839A2 (pt) 2015-10-20
WO2010000906A1 (es) 2010-01-07

Similar Documents

Publication Publication Date Title
NO2020022I1 (no) relebactam; eventuelt i form av monohydrat og imipenem
CY2020043I2 (el) Παγιδες gdf για χρηση στη θεραπευτικη αντιμετωπιση της αναιμιας
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK2107905T3 (da) Fast sammensætning omfattende alogliptin og pioglitazon
EP2249854A4 (en) IMPROVED TREATMENT AND PROPHYLAXIS
NO2017002I2 (no) Kobicistat eller farmasøytisk akseptabelt salt derav og atazanavir eller farmasøytisk akseptabelt salt derav
DK2342233T3 (da) Anti-CXCR4-antistoffer og anvendelse deraf i behandling af cancer
DK2114419T3 (da) Natriummetaarsenit til anvendelse i behandling af smerte og inflammation
SI2114447T1 (sl) Preprečevanje in zdravljenje subklinične PCVD
DK2193097T3 (da) Nanostrukturforstærkede kompositartikler og fremgangsmåder
WO2008106102A9 (en) Inhibitors of rtp801 and their use in disease treatment
DK2235002T3 (da) 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer
DK2154966T3 (da) Benzimidazoler og farmaceutiske sammensætninger deraf
EP2224928A4 (en) NOVEL INHIBITORS OF SEH AND THEIR USE
DK2001556T3 (da) Thioninium-forbindelser og anvendelse deraf
DK2308497T3 (da) Farmaceutisk sammensætning omfattende glycosaminoglycaner og brug heraf ved behandling af kroniske mavesår
IL204889A0 (en) Novel seh inhibitors and their use
DK2034999T3 (da) DHA-estere og anvendelse deraf i behandlingen og forebyggelsen af cardiovaskulære sygdomme
EP2217068A4 (en) NOVEL INHIBITORS OF SEH AND THEIR USE
BRPI0810475A2 (pt) uso de dimiracetam no tratamento de dor crônica
EP2209376A4 (en) NEW SEH-HEMMER AND ITS USE
EP2046368A4 (en) ANTI-COCAINE COMPOSITIONS AND TREATMENT
DK2341900T3 (da) Lægemiddelprodukt og behandling
FR2917947B1 (fr) Composition phytosanitaire pour le traitement preventif et curatif du mildiou
DK1984014T3 (da) Anvendelse af tpo-peptidforbindelser og farmaceutiske sammensætninger ved behandlingen af anæmi